- Trials with a EudraCT protocol (166)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
166 result(s) found for: Ocular hypertension.
Displaying page 8 of 9.
EudraCT Number: 2006-005237-38 | Sponsor Protocol Number: Alcon CMS-06-12 | Start Date*: 2007-06-27 | |||||||||||
Sponsor Name:Alcon Laboratories, Inc. | |||||||||||||
Full Title: SAFETY AND EFFICACY OF SWITCHING TO THE TRAVOPROST/TIMOLOL MALEATE FIXED COMBINATION (DUOTRAV) FROM PRIOR MONO- OR TWO-DRUG THERAPY IN GERMANY | |||||||||||||
Medical condition: primary open-angle glaucoma ocular hypertension pigment dispersion glaucoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001855-10 | Sponsor Protocol Number: SNAP1 | Start Date*: 2019-01-22 | |||||||||||
Sponsor Name:Department of Ophtalmology, Rigshospitalet-Glostrup | |||||||||||||
Full Title: Steroids and Non-steroidal Anti-inflammatory drugs in the Postoperative regime after trabeculectomy. An investigator-initiated randomized study (The SNAP study) | |||||||||||||
Medical condition: Medically uncontrolled glaucoma that requires filtration surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004106-25 | Sponsor Protocol Number: EOP 1011E | Start Date*: 2005-03-31 | |||||||||||
Sponsor Name:(OSI) Eyetech, Inc | |||||||||||||
Full Title: A Phase II randomised, dose-ranging, double-masked, multi-center trial, in parallel groups, to determine the safety, efficacy and pharmacokinetics of intravitreous injections of pegaptanib sodium c... | |||||||||||||
Medical condition: Exudative Age Related Macular Degeneration (AMD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001976-12 | Sponsor Protocol Number: DWP 815, 116.01.05 | Start Date*: 2005-06-20 |
Sponsor Name:Dr. Winzer Pharma | ||
Full Title: 12-monatige, prospektive klinische Phase IV-Prüfung zur Untersuchung der lokalen und systemischen Verträglichkeit von Clonid-Ophtal® 1/8% AT versus Tim-Ophtal® 0,5% AT bei Patienten mit okulärer Hy... | ||
Medical condition: Offenwinkelglaukom oder okuläre Hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-005378-12 | Sponsor Protocol Number: CL3-05153-006 | Start Date*: 2016-01-05 | ||||||||||||||||
Sponsor Name:Institut de Recherche Internationales Servier | ||||||||||||||||||
Full Title: Efficacy and Safety of Fixed-Dose Combination atorvastatin/amlodipine/perindopril versus Fixed-Dose Combination of atorvastatin/ amlodipine in Patients with Hypertension and Dyslipidemia. | ||||||||||||||||||
Medical condition: hypertension and dyslipidemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BG (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-001786-34 | Sponsor Protocol Number: IT-04-01 | Start Date*: 2005-05-16 | |||||||||||
Sponsor Name:ALCON ITALIA | |||||||||||||
Full Title: Hypotonic efficacy and tollerability of Travoprost in patient with open angle primary glaucoma and/or ocular hypertension, not controlled with dorzolamide + timolol treatment in fixed association... | |||||||||||||
Medical condition: Reducing high intraocular pressure in patient with ocular hypertension or open-angle glaucoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022128-63 | Sponsor Protocol Number: LX211-11 | Start Date*: 2011-03-16 |
Sponsor Name:Lux Biosciences, Inc. | ||
Full Title: A Multi-center, Double-Masked, Parallel Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Voclosporin as Therapy in Subjects with Active Non-Infectious Uveitis Involving the Inte... | ||
Medical condition: Non-Infectious Intermediate, Posterior or Pan-uveitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) AT (Completed) IT (Completed) GB (Completed) NL (Ongoing) CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004608-78 | Sponsor Protocol Number: LSFG-1.2 | Start Date*: 2017-03-03 | |||||||||||
Sponsor Name:Kepler University Hospital, Institute of Ophthalmology | |||||||||||||
Full Title: The Effect of Intravitreal Aflibercept on Ocular Perfusion – a Pilot Study | |||||||||||||
Medical condition: Exudative AMD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002601-30 | Sponsor Protocol Number: QTM/OMN0111 | Start Date*: 2011-09-26 | |||||||||||
Sponsor Name:OMNIVISION GmbH | |||||||||||||
Full Title: A COMPARISON OF LATANOPROST 50µg/ml EYE DROPS vs. XALATAN EYE DROPS IN THE TREATMENT OF OPEN ANGLE GLAUCOMA: AN OPEN, RANDOMIZED, CLINICAL TRIAL | |||||||||||||
Medical condition: Open angle glaucoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-002434-13 | Sponsor Protocol Number: 01-INSULINAGLAUCOMA-2022 | Start Date*: 2023-01-18 |
Sponsor Name:Barbara Burgos-Blasco | ||
Full Title: RANDOMIZED CLINICAL TRIAL DOUBLE BLIND (WITH BLIND EVALUATOR) TO DETERMINE THE EFFECTIVENESS AND SAFETY OF TOPICAL INSULIN IN THE TREATMENT OF DRY EYE IN PATIENTS WITH TOPICAL HYPOTENSIVE DRUGS | ||
Medical condition: Dry eye disease in glaucoma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003042-16 | Sponsor Protocol Number: IIBSP-PTE-2018-35 | Start Date*: 2019-02-08 |
Sponsor Name:Institut de Recerca H. de la Santa Creu i Sant Pau | ||
Full Title: Randomized clinical trial to evaluate the efficacy of fibrin membrane graft with eye drops concentrated in autologous growth factors in primary pterygium surgery comparing it with amniotic membrane... | ||
Medical condition: Pterigyum | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-006005-61 | Sponsor Protocol Number: PRN 05-001 | Start Date*: 2006-03-16 | |||||||||||
Sponsor Name:Pharmaceutical Research Network, LLC | |||||||||||||
Full Title: A COMPARISON OF THE EFFICACY AND SAFETY OF THE DORZOLAMIDE/TIMOLOL FIXED COMBINATION GIVEN TWICE DAILY VERSUS THE LATANOPROST/TIMOLOL FIXED COMBINATION GIVEN ONCE EVERY MORNING FOLLOWING A RUN-IN... | |||||||||||||
Medical condition: open-angle glaucoma ocular hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-005081-19 | Sponsor Protocol Number: 1 | Start Date*: 2014-07-10 | |||||||||||
Sponsor Name:HOSPICES CIVILS DELYON | |||||||||||||
Full Title: Phase II study evaluating the efficacy of aflibercept for the treatment of idiopathic choroidal neovascularization in young subjects: the INTUITION study | |||||||||||||
Medical condition: idiopathic choroidal neovascularization | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018853-36 | Sponsor Protocol Number: Cos_Gan_PR/09 | Start Date*: 2010-09-04 | |||||||||||
Sponsor Name:Prof. Stefano Gandolfi-Universita` degli studi di Parma | |||||||||||||
Full Title: Switching from beta blocker monotherapy to either ganfort � or cosopt �. A three months, single-blind , parallel group, randomized clinical trial in ocular hypertension/primary open angle glaucoma. | |||||||||||||
Medical condition: Primary open angle glaucoma or ocular hypertensive patients, any level of intraocular pressure. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001128-35 | Sponsor Protocol Number: A6641038 | Start Date*: 2005-06-02 | |||||||||||
Sponsor Name:Pfizer Pharma GmbH | |||||||||||||
Full Title: A 12-week randomised, evaluator-masked, parallel-group, multinational, multi-centre study comparing the efficacy and safety of the fixed combination of latanoprost and timolol (XalacomTM) with the ... | |||||||||||||
Medical condition: open angle glaucoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) SE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019505-42 | Sponsor Protocol Number: LEG-SIL-LTX-03 | Start Date*: 2010-05-26 |
Sponsor Name:Rottapharm SpA | ||
Full Title: ESTUDIO ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LEGALON SIL EN EL TRATAMIENTO DE LA RECURRENCIA DE VHC EN EL INJERTO DE PACIENTES SOMETIDOS A UN T... | ||
Medical condition: Pacientes de 18-70 años afectados por VHC en espera de de un trasplante ortotópico de hígado / 18-70 years old patients affected by HCV awaiting orthotopic liver transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-019975-30 | Sponsor Protocol Number: 35131 | Start Date*: 2010-08-24 | ||||||||||||||||
Sponsor Name:University Medical Center, Johannes Gutenberg-University Mainz | ||||||||||||||||||
Full Title: Investigation of the efficacy and safety of preoperative IOP reduction with preservative-free COSOPT-S® (dorzolamide/timolol, MSD) eye drops versus oral acetazolamide and dexamethasone eye drops an... | ||||||||||||||||||
Medical condition: Patients with glaucoma requiring trabeculectomy (filtration surgery) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002384-16 | Sponsor Protocol Number: TTD-11-01/AXI-IIG-01 | Start Date*: 2011-09-21 | |||||||||||
Sponsor Name:Grupo de Tratamiento de los Tumores Digestivos (TTD) | |||||||||||||
Full Title: A Phase II study of Axitinib as maintenance for patients with advanced colorectal carcinoma. | |||||||||||||
Medical condition: Advanced colorectal carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002238-35 | Sponsor Protocol Number: 11002X-001 | Start Date*: 2012-10-04 | |||||||||||
Sponsor Name:Allergan Ltd. | |||||||||||||
Full Title: A Multicenter, Double-masked, Randomized Study to Compare the Safety and Efficacy of an Investigational Eye Drop Formulation with OPTIVE™ Unit-Dose for 3 Months in Subjects with Dry Eye Disease | |||||||||||||
Medical condition: Dry Eye Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) DE (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000867-24 | Sponsor Protocol Number: ALFR-HC-04 | Start Date*: 2005-05-23 |
Sponsor Name:Human Genome Sciences, Inc. | ||
Full Title: A PHASE 2b, RANDOMIZED, MULTI-CENTER, ACTIVE-CONTROLLED, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALBUFERON (RECOMBINANT HUMAN ALBUMIN-INTERFERON ALFA FUSION PROTEIN) IN COMBINATION... | ||
Medical condition: Hepatitis type C chronic | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) CZ (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
